Abstract
Sterile inflammation resulting from cell death is due to the release of cell contents normally inactive and sequestered within the cell; fragments of cell membranes from dying cells also contribute to sterile inflammation. Endothelial cells undergoing stress-induced apoptosis release membrane microparticles, which become vehicles for proinflammatory signals. Here, we show that stress-activated endothelial cells release two distinct populations of particles: One population consists of membrane microparticles (<1 μm, annexin V positive without DNA and no histones) and another larger (1–3 μm) apoptotic body-like particles containing nuclear fragments and histones, representing apoptotic bodies. Contrary to present concepts, endothelial microparticles do not contain IL-1α and do not induce neutrophilic chemokines in vitro. In contrast, the large apoptotic bodies contain the full-length IL-1α precursor and the processed mature form. In vitro, these apoptotic bodies induce monocyte chemotactic protein-1 and IL-8 chemokine secretion in an IL-1α–dependent but IL-1β–independent fashion. Injection of these apoptotic bodies into the peritoneal cavity of mice induces elevated serum neutrophil-inducing chemokines, which was prevented by cotreatment with the IL-1 receptor antagonist. Consistently, injection of these large apoptotic bodies into the peritoneal cavity induced a neutrophilic infiltration that was prevented by IL-1 blockade. Although apoptosis is ordinarily considered noninflammatory, these data demonstrate that nonphagocytosed endothelial apoptotic bodies are inflammatory, providing a vehicle for IL-1α and, therefore, constitute a unique mechanism for sterile inflammation.
Keywords: ischemia/reperfusion, autoimmunity, lupus erythematosus
Although inflammation can be triggered by either bacterial or viral infection, sterile inflammation is the cause of most diseases, both acute and chronic (1). Sterile inflammation is characterized by extravasation of plasma proteins with leukocyte adhesion to endothelium followed by tissue infiltration. Whereas Toll-like receptor (TLR) ligands initiate inflammation via the induction of cytokines such as TNFα and IL-1, the mechanisms initiating sterile inflammation are less studied, particularly in response to tissue injury and ischemia. During myocardial infarction, stroke, or acute renal failure, sterile inflammation occurs in response to cell necrosis (1). In these cases, proteins called damage-associated molecular patterns or DAMPs, which are usually sequestered in the cytosol, are released from the cells because of the loss of membrane integrity. Among the so-called DAMPs is a group of poorly secreted preformed cytokines, notably high-mobility group box-1 (HMGB-1) and two members of the IL-1 family, IL-1α and IL-33 (1). These normally cytoplasmic proteins have a dual role; one as DNA binding proteins where they may function as transcription factors and the other outside the cell, where they bind to their specific cell membrane receptors. During the course of cellular apoptosis, these cytokines move to the nucleus and are sequestered by binding to chromatin; however, when a cell is undergoing necrosis, for example because of hypoxia, cellular contents are released and active forms trigger receptors on cells in the surrounding tissue (1–3).
Relevant to the presence of active membrane IL-1α (4–6), cells can communicate via the generation of various microvesicles issuing from membrane remodeling. During activation and apoptosis, the cell releases at least three types of bioactive vesicles, namely exosomes, membrane microparticles (MP), and apoptotic bodies (AptB) (7). Exosomes are vesicles <100 nm produced in endocytic multivesicular bodies, which express LAMP molecules but not phosphatidylserine and play an important role in antigen presentation (8). MP are larger (100 nm to 1 μm), membrane-derived vesicles expressing phosphatidylserine on the outer face of the membrane (7, 9–11), notably released from endothelial cells during exposure to a proinflammatory challenge such as TNFα (12), a prothrombotic product such as thrombin (13), or during cell apoptosis (7, 9). Their generation is associated with calcium flux into the cells, cytoskeletal reorganization, and membrane budding (9). MP carry several proteins from the parental cells and exert various prothrombotic and proinflammatory functions (9, 10, 14). For example, during rheumatoid arthritis, leukocyte MP induce metalloproteinase synthesis and chemokine secretion by synovial fibroblasts (15). Depending on the cell studied and the stimulus, i.e., activation versus apoptosis, MP appear heterogeneous and it is still debated whether they contain nucleic acid (16). Whereas MP carry RNA, they may contain very little if any DNA and histones, which are the hallmark of AptB (11, 17).
The third type of vesicles are AptB only produced during cell apoptosis (7, 9). These differ by their larger size (1–3 μm), although a few may be smaller (500 nm), phosphatidylserine outer membrane expression, and contain DNA and histones (7, 9). A commonly accepted paradigm is that AptB produced early in the course of cell apoptosis during senescence are rapidly phagocytosed by macrophages preventing immunization and inflammation, whereas nonphagocytosed AptB may become secondarily necrotic and have immune and inflammatory functions (2, 18).
Endothelial MP carry prothrombotic functions via phosphatidylserine and tissue factor expression on their membranes and are increased in patients with stroke or coronary heart diseases (11, 14). Similarly, via membrane expression of E-selectin, ICAM-1, and CD40 ligand, endothelial MP may have proinflammatory functions and are increased in atherosclerotic plaques or during vasculitis (14, 19). Although the proinflammatory functions of endothelial MP are well-established, the precise mechanisms supporting these functions, notably the role of inflammatory cytokines, are not well understood (20). Because the IL-1α precursor is constitutively present in endothelial cells and can be membrane-associated, we asked whether during apoptosis, IL-1α is released from endothelial cells by MP.
Results
Induction of HUVEC Apoptosis.
To re-create in vitro the inflammatory events of prothrombotic and hypoxic conditions on endothelial cells in vivo, we cultured HUVEC using low serum and growth factor concentrations combined with stimulation by TNFα. When cultured in the absence of serum and growth factors, HUVEC undergo several morphological changes of swelling and detachment (Fig. 1A, a and b). These changes become more prominent with TNFα stimulation (Fig. 1 A, c). In addition, with DAPI labeling, it appears that starvation-induced nuclear modifications such as fragmentation, increased after TNFα stimulation (Fig. 1A, a′– c′). These morphological changes are consistent with apoptosis. To confirm this observation, we first used annexin V (AnnV) and propidium iodide (PI) labeling and observed that double-labeled cells were significantly more numerous in HUVEC subjected to starvation and TNFα stimulation (22 ± 2.3%) compared with cells grown in normal medium (10.3 ± 1.4%) or in starved conditions alone (14.5 ± 2.9%) (Fig. 1B). We next assessed the presence of the cleaved form of caspase 3 and observed that both the 17- to 19-kDa bands representing the large fragment of the cleaved caspase-3 were clearly present in TNFα-stimulated starved HUVEC, but not in cells grown in normal medium (Fig. 1C). Similarly, using a specific monoclonal antibody, the presence of the cleaved form of caspase-3 was confirmed by immunofluorescence microscopy in the cytoplasm of TNFα-stimulated starved HUVEC (Fig. 1D). These data are consistent with the concept that serum starvation combined with TNFα stimulation induces HUVEC apoptosis.
Fig. 1.
Effect of serum starvation and stimulation with TNFα on apoptosis in HUVEC. (A) HUVEC cellular and nuclear morphology observed by light (a–c) or fluorescent microscopy after DAPI labeling (a’–c’). HUVEC were cultured in normal condition (N) or in starved conditions (STV) for 16 h, then stimulated with TNFα for 24 h (STV+TNFα); white arrows show cell nucleus fragmentation. (B) Percentage of AnnV-FITC and PI double-labeled HUVEC in each condition (*P < 0.05, n = 4). (C) Western blot of caspase-3 cleavage products in HUVEC under the conditions in A. The 17- to 19-kDa band representing the larger form of cleaved caspase 3 is observed in STV and STV+TNFα. Shown is one representative blot of three experiments. (D) Presence of cleaved caspase 3 using fluorescence microscopy in starved TNFα stimulated HUVEC. HUVEC were labeled with anti-cleaved caspase-3 mAb, and nuclei were counterstained with DAPI. One representative among three experiments.
Supernatants of Apoptotic HUVEC Contain a Heterogeneous Particulate Population.
Differential centrifugation allowed us to define 2 different populations of particles in the supernatants of TNFα-stimulated starved HUVEC. After a 300 × g centrifugation to remove dead cells and debris, a 4,500 × g centrifugation was performed on the supernatant (Fig. S1). This step resulted in the identification of two particulate populations in the pellet by flow cytometry analysis, each of which was labeled with AnnV: one predominant population with a size <1 μm and a population of larger particles between 1–3 μm (Fig. 2A, Left). We then subjected the 4,500 × g supernatant to ultracentrifugation (75,000 × g) to purify membrane MP. In agreement with previous reports (7), after ultracentrifugation, only the smaller AnnV positive particles were present in the pellet, whereas the large particles were nearly absent (Fig. 2A, Right). When using both DAPI and AnnV labeling of the 4,500 × g and 75,000 × g pellets, we observed that only the population of large particles was labeled, whereas no DAPI labeling was found in the population of small particles, notably those present in the 75,000 × g ultracentrifugation pellet (Fig. 2B). Similar data were obtained when combining AnnV and 7-AAD labeling (Fig. S2). Thus, sequential 4,500 × g centrifugation followed by ultracentrifugation allowed the separation of a population of large (1–3 μm) AnnV+/DAPI+ or 7-AAD+ particles from the dominant population of small (<1 μm) AnnV+/DAPI− or 7-AAD− particles released by the apoptotic HUVEC.
Fig. 2.
Characterization of fractions of particles in supernatants from stress-induced apoptosis in HUVEC. Supernatants of starved HUVEC (10 × 106 cells) stimulated with TNFα were centrifuged at 4,500 x g and 75,000 x g. (A) AnnV-FITC–positive particles from 4,500 x g and 75,000 x g pellets have different size distribution as estimated by forward scatter in flow cytometry. The y axis represents forward scatter. The x axis represents structure scatter. One representative among three different experiments. (B) Double staining using AnnV-FITC and DAPI separate the different particulate population from 4,500 x g and 75,000 x g pellets. Shown is one representative among three different experiments. (C) Western blotting of 4,500 x g and 75,000 x g pellets were analyzed by immunoblotting for the detection of histones using anti-H3 and anti–p-H2B Ab.
To better characterize the particulate population, we asked whether histones can be detected in the large particles. As shown in Fig. 2C, Western blot analysis showed that these particles contained ample amounts of H3 and p-H2B histones, whereas these histones were weakly detected in the 75,000 × g fraction. Together, these data are consistent with the concept that the large particle AnnV+/DAPI+/histone+ population represents apoptotic body-like particles, therefore designed as apoptotic bodies (AptB), whereas the small AnnV+/DAPI−/histone− particles found after ultracentrifugation represent membrane MP.
IL-1α Is Present in AptB but Not in MP.
Using an IL-1α immunoassay (Fig. 3A), we observed that IL-1α was significantly elevated in the 4,500 × g pellet from starved and TNFα-activated HUVEC compared with starved HUVEC. On the contrary, no significant concentration of IL-1α was detected in the 75,000 × g pellet from both starved and TNFα-activated HUVEC. Using flow cytometry analysis (Fig. 3B), we observed that IL-1α was detected in the AnnV+ 7-AAD+ AptB from the 4,500 × g pellet but not in the AnnV+ MP from the 75,000 × g pellet. To determine the molecular mass of IL-1α in AptB, we performed a Western blot analysis and observed that the 31-kDa precursor form, the 17-kDa mature form, and also an intermediate 23-kDa form of IL-1α were present in the 4,500 × g pellet (Fig. 3C). Very faint bands can be detected in 4,500 × g pellet from starved unstimulated HUVEC, whereas in agreement with the ELISA and cytometry data, no band was observed in the 75,000 × g pellet. All together, these data showed that IL-1α was present in AptB but not in MP. In addition, we submitted the 4,500 × g pellet to immunolabeling with anti–IL-1α mAb or control isotype followed by gold labeling and observed specific labeling with anti–IL-1α mAb but not with the control isotype using electron microscopy (Fig. 3D).
Fig. 3.
Detection of IL-1α in AptB but not in MP. (A) A concentration of 30.5 ± 5.3 pg of IL-1α /mg of protein (50 μg were used in all experiments) was measured by using specific ELISA in 4,500 x g pellet from TNFα-stimulated starved HUVEC (hatched bars) versus 1.2 ± 1 pg/mg in unstimulated starved HUVEC (open bars) (**P < 0.006, n = 3). In the 75,000 x g pellet, IL-1α was weakly detected in starved TNFα HUVEC, 4.3 ± 2.3 pg/mg of protein versus 0.3 ± 0.3 pg/mg in unstimulated starved HUVEC (P = ns). (B) Pellets [4,500 x g (Left) and 75,000 x g (Right)] of TNFα-stimulated starved HUVEC were labeled by AnnV-FITC, 7-AAD, and anti–IL-1α mAb before flow cytometry analysis. In the 4,500 x g pellet, double-stained events were analyzed for the presence of IL-1α. x and y axis represent, respectively, AnnV-FITC and 7-AAD labeling intensity distribution. FL2 axis represents IL-1α labeling intensity. Dotted line represents control isotype, and bold line represents anti–IL-1α labeling (one representative among three different experiments). (C) Western blotting of IL-1α in protein extracts (50 μg) obtained from 4,500 x g and 75,000 x g pellets of starved HUVEC (STV) or stimulated with TNFα (STV+TNFα). Recombinant IL-1α (2 ng) is running as a positive control (one representative among three experiments). (D) Pellets (4,500 x g) of TNFα-stimulated starved HUVEC were labeled with anti–IL-1α mAb (Left) or control isotype (Right) and revealed by beads gold-labeled secondary Ab before electronic microscopy. (Scale bar: 500 nm.)
AptB but Not MP Induce Chemokine Production from HUVEC via an IL-1α–Mediated Mechanism.
Endothelial-derived AptB and MP were compared for their proinflammatory properties in vitro. As shown in Fig. 4, when added to monolayer cultures of HUVEC, AptB induced the secretion of IL-8 (Fig. 4A) and MCP-1 (Fig. 4B). AptB from starved HUVEC induced low levels of IL-8, whereas AptB from starved and TNFα-activated HUVEC induced significant IL-8 production, which was nearly completely inhibited by addition of IL-1Ra or anti-IL-1α mAb (Fig. 4A). However, anti–IL-1β did not affect IL-8 induced by AptB, whereas anti–IL-1β completely inhibited recombinant IL-1β–induced IL-8 production (Fig. S3). Similar data were obtained when measuring MCP-1 production from HUVEC in response to AptB (Fig. 4B). In parallel experiments, we studied the capacity of MP obtained from starved and TNFα-stimulated HUVEC to induce chemokine production. In contrast to AptB, MP did not induce significant production of chemokines (Fig. 4 C and D). These results identified IL-1α as the primary mediator of the proinflammatory effect of AptB generated from HUVEC.
Fig. 4.
Comparison and IL-1α dependence of in vitro chemokine production between AptB and MP. AptB (4,500 x g pellet) (A and B) and MP (75,000 x g pellet) (C and D) from unstimulated starved HUVEC (open bars) or stimulated with TNFα (hatched bars) were counted as described in Materials and Methods and added in a 5:1 ratio (particles per cell) to HUVEC monolayers in the presence or absence of anti–IL-1α, anti–IL-1β, anti-TNFα neutralizing Ab or IL-1Ra. After 16 h of coculture, supernatants were discarded and IL-8 (A and C) or MCP-1 (B and D) were measured by using specific ELISA (*P < 0.05, **P < 0.01, ***P < 0.001, respectively; n = 3–6).
i.p. Injection of AptB into Mice Induces Serum KC and a Local Neutrophilic infiltration.
To determine whether the chemokine-inducing property of AptB is active in vivo, we injected these particles into the peritoneal cavity of mice. Fifteen hours after the injection, there was an increase in the number of peritoneal cavity leukocytes (Fig. 5A). As shown in Fig. 5B, these leukocytes consisted mostly of neutrophils (2.1-fold increase). Moreover, injection of IL-1Ra a few minutes before AptB completely prevented the neutrophil influx (Fig. 5 A and B). In the same experiments, no significant increase of monocyte count was observed after the injection of AptB (Fig. S4). In agreement with these data, the concentration of KC (mouse form of human IL-8) was significantly increased in the sera of mice injected with the particles (threefold increase) but not in animals cotreated with IL-1Ra (Fig. 5C).
Fig. 5.
IL-1α–dependent inflammatory responses after i.p. injection of AptB. (A) Leukocytes (5.3 ± 0.6 x106) were measured by flow cytometry after the injection of 30 × 106 AptB into the peritoneal cavity versus 3.5 ± 0.2 x 106 in PBS condition. Injection of 30 mg/kg IL-1Ra before the injection of AptB induce significant reduction of leukocytes measured in peritoneal fluid (*P < 0.05). (B) Neutrophils (5.7 ± 0.6 x 105) from data shown in A were measured by flow cytometry in peritoneal fluid after injection of AptB compared with 2.7 ± 0.5 x 105 neutrophils in PBS condition and 2.2 ± 0.6 x 105 in AptB and IL-1Ra condition (**P < 0.01). (C) KC concentrations (121 ± 20 pg/mL) obtained in serum 15 h after the i.p. injection of the AptB versus 39 ± 14 pg/mL in vehicule condition and 56.5 ± 21.2 in AptB + IL-1Ra condition (*P < 0.05; ANOVA test). Five independent experiments represent a total number of 6–11 mice for each condition.
Discussion
At least two different particulate populations could be isolated from the supernatants of inflammatory apoptotic HUVEC. One predominant population of <1 μm, AnnV+/DAPI−/histone− particles mainly represents MP (9). These MP did not induce in vitro chemokine secretion or express IL-1α as anticipated. MP, including endothelial MP (12), are known to carry the surface proteins from their parent cells and to exert various proinflammatory properties as shown in rheumatoid arthritis (15). However, despite the fact that IL-1α is often membrane-associated and that IL-1β is expressed in MP harvested from ATP-stimulated mononuclear cells (21), their proinflammatory role in rheumatoid arthritis has been shown to be largely IL-1– and TNFα-independent (20). A report, however, has demonstrated that MP originating from collagen-activated platelets exert IL-1–mediated proinflammatory properties in an animal model of rheumatoid arthritis and express IL-1α (22). The reasons for these discrepancies may be due to the difference of cell sources, activation mechanisms, and MP preparation methods, which remain major issues in this field (9). It should be noted, however, that in reports including one from our group, studying IL-1 in platelets, IL-1β, and not IL-1α was reported to be present in platelets (23–25).
A second particulate population was isolated from inflammatory apoptotic HUVEC, which are 1–3 μm, AnnV+/DAPI+/histone+. These particles are different from exosomes because they are much larger (1–3 μm vs. 20–100 nm) and express AnnV (7). In addition, these particles are also different from MP because their size is larger than 0.1–1 μm and they contain nucleic acid material and histones (7, 9). The characteristics of these particles are thus consistent with AptB (7, 9). Some authors have reported that the size of AptB may be smaller, ≈500 nm (17) and, indeed, our preparation of MP may be contaminated by some small AptB, explaining the presence of a few DAPI+/histone+ particles; however, the majority of AptB in our experiments appear larger and can be differentiate from MP by both their size, DNA, and histones contained. Contrary to MP, these AptB contained IL-1α in both the precursor and mature form, and were able to induce chemokine secretion in vitro and in vivo as well as neutrophilic inflammation in vivo, in a way that appeared to be totally IL-1–mediated. The IL-1α precursor is biologically active and binds to the IL-1 surface receptor. Because the IL-1α precursor or the propiece translocates to the nucleus (26, 27), nuclear IL-1α may be the source, in part, of IL-1α in the AptB. During apoptosis, the entire precursor translocates into the nucleus and remains tightly associated with chromatin (28). It seems that nuclear IL-1α precursor is incorporated into the AptB as induced in HUVEC in the present studies indicate and contributes to the sterile neutrophilic inflammation (3, 29, 30).
The noninflammatory properties of apoptotic cells constitute a frequently accepted paradigm that when cell apoptosis occurs during the physiological processes of tissue senescence and renewal in the absence of any stress signal, there is little or no inflammation (31). However, when cell apoptosis occurs in the context of an inflammatory stress, apoptotic cells form and release plasma-membrane–derived structures including MP and AptB. These can be characterized by the presence of different surface markers, but these plasma-membrane–derived structures can possibly contain death-associated molecules that can amplify an inflammatory response (32). Moreover, it has been shown that necrosis is also a programmed cell-death mechanism that can coexist with or follow apoptosis (33). In the present experiments, apoptosis was induced in vitro in the absence of macrophages, thus AptB are not phagocytosed and can follow the process of so-called “secondary necrosis,” constituting secondary necrotic AptB. Similarly to HMGB-1, another important dual-function cytokine that is associated with chromatin during apoptosis and released in an active form from the nucleus during late apoptosis or necrosis (34), the 31-kDa IL-1α precursor is present in the AptB likely associated with chromatin. However, during the process of secondary necrosis, the 31-kDa form of IL-1α may be released from the chromatin and cleaved by calpain-like (or other) enzymes in its 17-kDa mature form (35), which was unexpectedly found in large amounts in our experiments. Interestingly, calpain is known to be activated during necrosis usually through calcium influx into the cell, but also under the action of caspase 3, a main player of apoptosis, through inactivation of calpastatin, an endogenous calpain inhibitor (36).
If “secondary necrotic” apoptotic cells or bodies are commonly observed in vitro, what is their relevance in vivo? The equilibrium between cell death and macrophage phagocytosis is of major importance for homeostasis and perturbations of this equilibrium may lead to detrimental inflammation or auto-immune diseases (2, 32). For example, during severe tissue ischemia such as heart attack or stroke, in which massive cell apoptosis largely overcomes the phagocytosis ability of surrounding macrophages, secondary necrosis can occur and induce a pronounced neutrophilic inflammation. In this situation, central nervous system neurons have indeed been shown to express active forms of both caspase 3 and calpain enzymes, thus coexistence of apoptosis and necrosis (37). Interestingly, the role of IL-1 during ischemia/reperfusion-induced inflammation is now largely demonstrated and IL-1 therapy is considered a promising strategy (38).
Alternatively, some individuals may have a defective clearance of AptB, as shown in systemic lupus erythematosus explaining why AptB persist in tissues, favoring the immunization against the nuclear components constitutive of the nucleosome structures (18, 39). Moreover, in these patients, proapoptotic and inflammatory situations such as UVB-exposure, a well-known lupus flare condition, may induce accumulation of secondary necrotic AptB and induction of inflammation. Consistent with this hypothesis, the presence of circulating nucleosomes containing an active form of HMGB-1 has been recently reported in patients with systemic lupus erythematosus and found to favor a proinflammatory phenotype and anti-DNA immunization (40).
These data support the important role of IL-1α released from necrotic cells in the induction of neutrophilic sterile inflammation. Activation of resident or recruited macrophages by IL-1α may then occur leading to IL-1β secretion and amplification of the inflammatory response to sterile stimuli (3, 41). Although DNA, histones, uric acid or HMGB-1 have been implicated as a cause of sterile inflammation (1), it is likely that IL-1 family members play a central role in the inflammation induced by apoptotic/necrotic cell death and its potential therapeutic relevance (41).
Materials and Methods
Reagents and Antibodies.
Earle's modified 199 medium, Dulbecco's PBS (PBS) without CaCl2 and MgCl2, donkey Alexa Fluor 594-conjugated anti-rabbit IgG antibody (Ab) were obtained from Invitrogen Life Technologies and EGM2 medium from Clonetics (Lonza). 4',6'-diamidino-2-phénylindole (DAPI), paraformaldehyde (PFA) and polymyxin B were purchased from Sigma Aldrich Chimie. ECL Plus Western blotting detection system kit was obtained from GE Healthcare Europe. Fluorescein isothiocyanate (FITC)-conjugated annexin V (AnnV-FITC), 7-AAD, PI, Phycoerythrin (PE)-conjugated goat anti-mouse IgG (H+L) Ab were purchased from Beckman Coulter. Recombinant human TNFα was obtained from Active Bioscience. Recombinant human IL-1α (200-LA), anti-human IL-1α mAb (MAB200, IgG2a, clone 4414.141), goat anti-human TNFα Ab (AF-210-NA) were purchased from R&D Systems Europe. Rabbit anti-human IL-1β polyclonal Ab and IL-1Ra were from Charles Dinarello. Rabbit anti-human cleaved caspase-3 mAb (Asp175) (5A1E) was obtained from Cell Signaling (Ozyme). Mouse irrelevant IgG2a, rat anti-mouse Ly6G-FITC (Gr1, RB6-8C5), rat anti-mouse CD11b-Allophycocyanin (APC) (M1/70) Ab were purchased from eBioscience. Rat anti-mouse CD45-PE Ab (30-F11) was from BD Bioscience. Rabbit control IgG, rabbit anti-human histone H3 (FL-136), goat anti-human IL-1α (C-18) Ab were purchased from Santa Cruz Biotechnology. Rabbit anti-phospho-human histone H2B (Ser-14) Ab was obtained from Millipore. Fifteen-nanometer beads gold-labeled Ab was obtained from BB International.
Eight- to 10-week-old male C57BL/6J mice were purchased from Charles River Laboratories.
Cells.
Human umbilical vein endothelial cells (HUVEC) were isolated as previously reported (6), grown in EGM2 and used between passages 2 and 4. When required, HUVEC were starved of serum and growth factors by culturing in M199 with 5% 0.22-μm filtered MP-free FCS (FCS) during 16 h before 50 ng/mL TNFα stimulation for 24 h to induce particles generation.
In some experiments HUVEC monolayers were incubated for 16 h with freshly obtained particles (5 particles per 1 HUVEC ratio) in the presence of 7 μg/mL polymyxin B and various inhibitors such as 200 ng/mL IL-1Ra, 1 μg/mL anti-IL-1α, 1 μg/mL anti–IL-1β, or 25 ng/mL anti-TNFα Ab, before supernatants were discarded, centrifuged, and assayed for chemokine concentrations.
Apoptosis Assays.
Nonadherent and trypsinized HUVEC were pooled then labeled with AnnV-FITC, and later PI and analyzed by flow cytometry. In other experiments, HUVEC were grown in eight-well culture slides, fixed with 1% PFA, then incubated with PBS containing 0.1% Triton X-100 for 1 h. Cells were incubated with rabbit anti-human cleaved caspase-3 mAb or with 4 μg/mL control rabbit IgG for 1 h at 4 °C, before the addition of donkey Alexa Fluor 594-conjugated 2 μg/mL anti-rabbit IgG for 45 min. Cells were then colabeled with DAPI and analyzed on TE2000-U epi-fluorescence microscope (Nikon Instruments Europe BV).
Generation, Numeration, and Characterization of Particulate Populations.
Endothelial particles were obtained from the supernatants of starved HUVECs, either unstimulated or stimulated with TNFα after a three-step centrifugation method, as described in Fig. S1. Particles were analyzed by flow cytometry using a Coulter FC500 with CXP software (Beckman Coulter) as reported (42). Two different gates were defined, the first one included particles between 1 and 3 μm whereas the second one included particles between 0.5 and 1 μm. Protocol setting and gates were adjusted by using 0.5-, 0.9-, and 3-μm Megamix beads (Biocytex). The presence of nucleic acid was determined by using 4,500 × g and 75,000 × g pellets colabeling with AnnV-FITC and DAPI or 7-AAD. To detect the presence of IL-1α, 106 particles of either 4,500 × g and 75,000 × g pellets were incubated at 4 °C for 1 h with 8 μg/mL anti–IL-1α mAb or 8 μg/mL control IgG2a Ab in 0.1% saponin containing PBS then revealed by addition of goat PE-conjugated anti-mouse IgG. After washing, 4,500 × g and 75,000 × g pellets were costained with AnnV-FITC and 7-AAD.
Protein Extraction.
Trypsinized HUVEC, 4,500 × g and 75,000 × g pellets were lysed in a buffer containing 1% Triton X-100, 25mM Hepes at pH 7.5, 150 mM NaCl, 1 mM EDTA, 100 μM leupeptin, 10 μg/mL aprotinin, 10 μM pepstatin A, and 1 mM phenylmethylsulfonyl fluoride. Respective lysates were centrifuged at 20,000 × g for 15 min and the supernatants recovered. Protein concentrations were measured by micro BCA protein assay kit (Pierce, Perbio Science), whereas the remaining supernatants were stored at –80 °C until assayed IL-1α by Western blot (WB) or ELISA.
For WB, samples of respective lysates containing equal amounts of protein (30–50 μg) were separated by continuous SDS/PAGE on 12% or 15% slab gels then transferred to nitrocellulose membranes (Schleicher and Schuell). Blots were blocked with TBST (150 mM NaCl, 50 mM Tris⋅HCl at pH 7.5, 0.1% Tween 20) with 3% BSA for 30 min then probed with rabbit anti-human histone H3 (1:1,000), rabbit anti-human phospho-histone H2B (1:10,000), rabbit anti-human cleaved caspase-3 (1:1,000), or goat anti-human IL-1α (1:1,000) Ab. Membranes were then incubated with respective secondary antibodies conjugated to horseradish peroxidase and specific bands revealed by using ECL Plus WB detection system.
Electronic Microscopy.
Ten-microliters of the 4,500 × g pellet isolated from TNFα-stimulated starved HUVECs were applied to 100 mesh nickel formvar-carbon–coated grids (Agar Scientific) for 10 min. Samples were fixed with PBS containing 2% PFA and 0.2% glutaraldehyde, incubated with 5 μg/mL anti-human IL-1α mAb or irrelevant mouse IgG2a, then incubated with beads gold-labeled Ab for 1 h. Grids were negatively stained with 0.3% phosphotungstic acid before observation with JEOL 1220 electron microscope.
Cytokine Assays.
Measurements of IL-1α, IL-8, and MCP-1 were performed with specific ELISA (R&D Systems).
Animal Studies.
Animal studies were approved by the local ethical committee. C57BL/6J mice received i.p. injections of PBS or IL-1Ra (30mg/kg), then injections of either 30 × 106 particles from the 4,500 × g pellet in PBS or PBS alone. Fifteen hours after the injections, animals were killed and peritoneal cavities were washed with 2 mL of PBS. Peritoneal fluid was harvested in EDTA tubes, and blood was collected by intracardiac puncture for serum collection. In each sample, the total number of leukocytes, neutrophils, or monocytes in the peritoneal exudate cells was determined by the count of CD45+, CD45+/Ly-6G+/CD11b− or CD45+/Ly-6G−/CD11b+ cells, respectively, using a Gallios flow cytometer and Fluorescent beads Flowcount (Beckman Coulter).
Statistical Analyses.
Data represent the cumulative results of all experiments and are expressed as mean ± SE [or median [25th – 75th) for Fig. 4] for the indicated number of experiments (n). Statistical analysis was performed with Graph Pad Prism version 4 software (GraphPad Software). Significant differences were determined by using nonparametric Mann–Whitney test (or ANOVA test for Fig. 5C). P values <0.05 were considered statistically significant.
Supplementary Material
Acknowledgments
This study was supported by Université de la Méditerranée, Institut National de la Santé et de la Recherche Médicale and Assistance Publique Hôpitaux de Marseille. C.A.D. is supported by National Institutes of Health Grants AI–15614 and AR–45584.
Footnotes
The authors declare no conflict of interest.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1116848108/-/DCSupplemental.
References
- 1.Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response. Annu Rev Immunol. 2010;28:321–342. doi: 10.1146/annurev-immunol-030409-101311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Zitvogel L, Kepp O, Kroemer G. Decoding cell death signals in inflammation and immunity. Cell. 2010;140:798–804. doi: 10.1016/j.cell.2010.02.015. [DOI] [PubMed] [Google Scholar]
- 3.Rider P, et al. IL-1alpha and IL-1beta recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol. 2011;187:4835–4843. doi: 10.4049/jimmunol.1102048. [DOI] [PubMed] [Google Scholar]
- 4.Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–550. doi: 10.1146/annurev.immunol.021908.132612. [DOI] [PubMed] [Google Scholar]
- 5.Kurt-Jones EA, Fiers W, Pober JS. Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts. J Immunol. 1987;139:2317–2324. [PubMed] [Google Scholar]
- 6.Kaplanski G, et al. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood. 1994;84:4242–4248. [PubMed] [Google Scholar]
- 7.Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581–593. doi: 10.1038/nri2567. [DOI] [PubMed] [Google Scholar]
- 8.Théry C, et al. Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles. J Immunol. 2001;166:7309–7318. doi: 10.4049/jimmunol.166.12.7309. [DOI] [PubMed] [Google Scholar]
- 9.Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS. Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity. 2006;39:683–690. doi: 10.1080/08916930601061538. [DOI] [PubMed] [Google Scholar]
- 10.Ardoin SP, Pisetsky DS. The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation. Mod Rheumatol. 2008;18:319–326. doi: 10.1007/s10165-008-0054-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Morel O, Jesel L, Freyssinet JM, Toti F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol. 2011;31:15–26. doi: 10.1161/ATVBAHA.109.200956. [DOI] [PubMed] [Google Scholar]
- 12.Combes V, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest. 1999;104:93–102. doi: 10.1172/JCI4985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Sapet C, et al. Thrombin-induced endothelial microparticle generation: Identification of a novel pathway involving ROCK-II activation by caspase-2. Blood. 2006;108:1868–1876. doi: 10.1182/blood-2006-04-014175. [DOI] [PubMed] [Google Scholar]
- 14.Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol. 2011;31:27–33. doi: 10.1161/ATVBAHA.110.218123. [DOI] [PubMed] [Google Scholar]
- 15.Distler JH, et al. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci USA. 2005;102:2892–2897. doi: 10.1073/pnas.0409781102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Reich CF, 3rd, Pisetsky DS. The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis. Exp Cell Res. 2009;315:760–768. doi: 10.1016/j.yexcr.2008.12.014. [DOI] [PubMed] [Google Scholar]
- 17.Schiller M, et al. Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ. 2008;15:183–191. doi: 10.1038/sj.cdd.4402239. [DOI] [PubMed] [Google Scholar]
- 18.Pisetsky DS, Rönnblom L. Systemic lupus erythematosus: A matter of life and death. Arthritis Rheum. 2009;60:1567–1570. doi: 10.1002/art.24531. [DOI] [PubMed] [Google Scholar]
- 19.Leroyer AS, et al. CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J Am Coll Cardiol. 2008;52:1302–1311. doi: 10.1016/j.jacc.2008.07.032. [DOI] [PubMed] [Google Scholar]
- 20.Distler JH, Distler O. Inflammation: Microparticles and their roles in inflammatory arthritides. Nat Rev Rheumatol. 2010;6:385–386. doi: 10.1038/nrrheum.2010.87. [DOI] [PubMed] [Google Scholar]
- 21.MacKenzie A, et al. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity. 2001;15:825–835. doi: 10.1016/s1074-7613(01)00229-1. [DOI] [PubMed] [Google Scholar]
- 22.Boilard E, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science. 2010;327:580–583. doi: 10.1126/science.1181928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Hawrylowicz CM, Howells GL, Feldmann M. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med. 1991;174:785–790. doi: 10.1084/jem.174.4.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kaplanski G, et al. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood. 1993;81:2492–2495. [PubMed] [Google Scholar]
- 25.Lindemann S, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol. 2001;154:485–490. doi: 10.1083/jcb.200105058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wessendorf JH, Garfinkel S, Zhan X, Brown S, Maciag T. Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor. J Biol Chem. 1993;268:22100–22104. [PubMed] [Google Scholar]
- 27.Werman A, et al. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc Natl Acad Sci USA. 2004;101:2434–2439. doi: 10.1073/pnas.0308705101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Cohen I, et al. Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc Natl Acad Sci USA. 2010;107:2574–2579. doi: 10.1073/pnas.0915018107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Chen CJ, et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med. 2007;13:851–856. doi: 10.1038/nm1603. [DOI] [PubMed] [Google Scholar]
- 30.Eigenbrod T, Park JH, Harder J, Iwakura Y, Núñez G. Cutting edge: Critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells. J Immunol. 2008;181:8194–8198. doi: 10.4049/jimmunol.181.12.8194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature. 2000;407:784–788. doi: 10.1038/35037722. [DOI] [PubMed] [Google Scholar]
- 32.Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol. 2009;9:353–363. doi: 10.1038/nri2545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Golstein P, Kroemer G. Cell death by necrosis: Towards a molecular definition. Trends Biochem Sci. 2007;32:37–43. doi: 10.1016/j.tibs.2006.11.001. [DOI] [PubMed] [Google Scholar]
- 34.Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev. 2007;220:35–46. doi: 10.1111/j.1600-065X.2007.00574.x. [DOI] [PubMed] [Google Scholar]
- 35.Kobayashi Y, et al. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha. Proc Natl Acad Sci USA. 1990;87:5548–5552. doi: 10.1073/pnas.87.14.5548. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Harwood SM, Yaqoob MM, Allen DA. Caspase and calpain function in cell death: Bridging the gap between apoptosis and necrosis. Ann Clin Biochem. 2005;42:415–431. doi: 10.1258/000456305774538238. [DOI] [PubMed] [Google Scholar]
- 37.Newcomb-Fernandez JK, et al. Concurrent assessment of calpain and caspase-3 activation after oxygen-glucose deprivation in primary septo-hippocampal cultures. J Cereb Blood Flow Metab. 2001;21:1281–1294. doi: 10.1097/00004647-200111000-00004. [DOI] [PubMed] [Google Scholar]
- 38.Wanderer AA. Ischemic-reperfusion syndromes: Biochemical and immunologic rationale for IL-1 targeted therapy. Clin Immunol. 2008;128:127–132. doi: 10.1016/j.clim.2008.03.514. [DOI] [PubMed] [Google Scholar]
- 39.Gaipl US, et al. Clearance deficiency and systemic lupus erythematosus (SLE) J Autoimmun. 2007;28:114–121. doi: 10.1016/j.jaut.2007.02.005. [DOI] [PubMed] [Google Scholar]
- 40.Urbonaviciute V, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: Implications for the pathogenesis of SLE. J Exp Med. 2008;205:3007–3018. doi: 10.1084/jem.20081165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Dinarello CA. Anti-inflammatory agents: Present and future. Cell. 2010;140:935–950. doi: 10.1016/j.cell.2010.02.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Robert S, et al. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: A first step towards multicenter studies? J Thromb Haemost. 2009;7:190–197. doi: 10.1111/j.1538-7836.2008.03200.x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.





